FederalMD
Open
Aug 12, 2026
Closes
Aug 24, 2026
Brightfield Group Online Data Subscription and Analytic Services
The Food and Drug Administration (FDA) requires Brightfield Group online data subscription and analytic services to address knowledge gaps concerning cannabis, cannabidiol (CBD), and emerging products. The services are intended to inform FDA work on policy and regulation, education and outreach, and compliance activities. SAM.gov lists the opportunity as an active Combined Synopsis/Solicitation (Original), with offers due August 24, 2026 at 1:00 pm EDT.
